LivingGLP1
Study S001481

Effectiveness and Safety of Tirzepatide (t.g.) in Patients Treated at the Obesity Unit of the Department of Endocrinology of the Hospital de Clínicas, Faculty of Medical Sciences, UNA: Phase 4 Study

Registration

Registration
NCT07492563
Study type
OBSERVATIONAL
Status
NOT_YET_RECRUITING
Enrollment
300
Start
2026-03
Primary completion
2026-10
Lead sponsor
LABORATORIOS INDUFAR
Conditions
Obesity; Type 2 Diabetes Mellitus; Overweight With Comorbidities
Interventions
DRUG:Tirzepatide (T.G.)
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Incidence of Adverse Events [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.